- Home
- NBHC vs SUPN Comparison
NBHC vs SUPN Comparison
Compare NBHC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBHC
- SUPN
- Stock Information
- Founded
- NBHC 2009
- SUPN 2005
- Country
- NBHC United States
- SUPN United States
- Employees
- NBHC N/A
- SUPN N/A
- Industry
- NBHC Major Banks
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- NBHC Finance
- SUPN Health Care
- Exchange
- NBHC Nasdaq
- SUPN Nasdaq
- Market Cap
- NBHC 1.5B
- SUPN 1.8B
- IPO Year
- NBHC 2012
- SUPN 2012
- Fundamental
- Price
- NBHC $40.55
- SUPN $33.96
- Analyst Decision
- NBHC Hold
- SUPN Hold
- Analyst Count
- NBHC 5
- SUPN 2
- Target Price
- NBHC $46.80
- SUPN $36.00
- AVG Volume (30 Days)
- NBHC 261.3K
- SUPN 739.8K
- Earning Date
- NBHC 07-22-2025
- SUPN 08-05-2025
- Dividend Yield
- NBHC 2.98%
- SUPN N/A
- EPS Growth
- NBHC N/A
- SUPN N/A
- EPS
- NBHC 2.89
- SUPN 1.11
- Revenue
- NBHC $389,883,000.00
- SUPN $667,997,000.00
- Revenue This Year
- NBHC $12.13
- SUPN N/A
- Revenue Next Year
- NBHC $6.96
- SUPN $12.02
- P/E Ratio
- NBHC $13.92
- SUPN $29.92
- Revenue Growth
- NBHC N/A
- SUPN 11.82
- 52 Week Low
- NBHC $32.83
- SUPN $27.05
- 52 Week High
- NBHC $51.76
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- NBHC 67.43
- SUPN 66.18
- Support Level
- NBHC $39.10
- SUPN $32.49
- Resistance Level
- NBHC $40.46
- SUPN $33.80
- Average True Range (ATR)
- NBHC 0.79
- SUPN 0.91
- MACD
- NBHC 0.25
- SUPN 0.23
- Stochastic Oscillator
- NBHC 99.72
- SUPN 99.37
About NBHC National Bank Holdings Corporation
National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.